Efficacy of biologic and small molecule agents as second髄ine therapy after exposure to TNF inhibitors in patients with ulcerative colitis: a propensity髆atched cohort …

GS Kochhar, A Desai, FA Farraye… - Alimentary …, 2023 - Wiley Online Library
Background There is limited real體orld data on comparative effectiveness of different
biologic or small molecule agents as second髄ine therapies in patients with ulcerative colitis …
被引用次数：10 相关文章

Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort …

GS Kochhar, A Desai, FA Farraye… - Alimentary …, 2023 - pubmed.ncbi.nlm.nih.gov
Background There is limited real-world data on comparative effectiveness of different
biologic or small molecule agents as second-line therapies in patients with ulcerative colitis …

Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort …

GS Kochhar, A Desai, FA Farraye… - Alimentary …, 2023 - scholars.northwestern.edu
Background: There is limited real-world data on comparative effectiveness of different
biologic or small molecule agents as second-line therapies in patients with ulcerative colitis …

Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort …

GS Kochhar, A Desai, FA Farraye… - Alimentary …, 2023 - europepmc.org
Background There is limited real-world data on comparative effectiveness of different
biologic or small molecule agents as second-line therapies in patients with ulcerative colitis …